News from bluewind medical A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 06, 2020, 09:00 ET BlueWind Medical Appoints Dan Lemaitre as Chief Executive Officer

BlueWind Medical, developer of the RENOVA iStim™, an innovative, leadless, miniature neurostimulation platform initially being developed for the...


Nov 19, 2018, 09:00 ET BlueWind Medical Appoints New Executive Chairman

BlueWind Medical, developer of a miniature, wireless neurostimulation platform for the treatment of multiple clinical indications, is pleased to...


Nov 19, 2018, 09:00 ET BlueWind Medical nomme un nouveau président exécutif

Daniel Lemaitre apporte plus de trois décennies d'expérience dans le domaine des dispositifs médicaux BlueWind Medical, une...


Aug 30, 2018, 08:30 ET BlueWind Medical Announces Positive Long-Term Results of the BLUEWIND-RENOVA™ Implantable Tibial Nerve Neuromodulator

BlueWind Medical, developer of the RENOVA iStim™, an innovative, leadless, miniature, wireless neurostimulation platform, for the treatment of...


Jul 30, 2018, 10:30 ET BlueWind Medical Appoints Dr. Roger R. Dmochowski, MD, MMHC, as Chief Medical Officer

BlueWind Medical, a developer of a miniature, wireless neurostimulation platform for the treatment of multiple clinical indications, announced today...


Jul 30, 2018, 04:00 ET BlueWind Medical Appoints Dr. Roger R. Dmochowski, MD, MMHC, as Chief Medical Officer

BlueWind Medical, a developer of a miniature, wireless neurostimulation platform for the treatment of multiple clinical indications, announced today...


Jun 15, 2018, 04:00 ET BlueWind Medical reçoit l'approbation de la FDA pour la conception de l'étude pivot portant sur RENOVA iStim™, un neuromodulateur implantable dans le nerf tibial dans le cadre de l'hyperactivité vésicale

BlueWind Medical, entreprise qui développe une plateforme de neurostimulation miniature sans fil, destinée au traitement de multiples indications...


Jun 15, 2018, 04:00 ET BlueWind Medical ottiene approvazione dell'FDA per disegno di studio pivot del neuromodulatore del nervo tibiale impiantabile RENOVA iStim™ per la vescica iperattiva

BlueWind Medical, azienda che ha sviluppato una piattaforma miniaturizzata di neurostimolazione per il trattamento di varie indicazioni cliniche, ha...


Jun 15, 2018, 04:00 ET BlueWind Medical ontvangt goedkeuring van de FDA voor essentieel proefontwerp van RENOVA iStim™ implanteerbare scheenbeenzenuw-neuromodulator voor een overactieve blaas

BlueWind Medical, een ontwikkelaar van een miniatuur draadloos neurostimulatie-platform, voor de behandeling van verschillende klinische...


Jun 15, 2018, 04:00 ET BlueWind Medical erhält FDA-Zulassung für Schlüsselstudie des implantierbaren Tibialisnerv-Neuromodulators RENOVA iStim™ für die Behandlung der überaktiven Blase

BlueWind Medical, der Entwickler einer drahtlosen Miniatur-Neurostimulationsplattform für die Behandlung mehrerer klinischer Indikationen, gab heute...


Jun 14, 2018, 09:00 ET BlueWind Medical Receives FDA Approval for Pivotal Trial Design of RENOVA iStim™ Implantable Tibial Nerve Neuromodulator for Overactive Bladder

BlueWind Medical, a developer of a miniature wireless neurostimulation platform, for the treatment of multiple clinical indications, announced today...


Jan 04, 2018, 08:00 ET BlueWind Medical Announces the Publication of Breakthrough Results for BLUEWIND-RENOVA™ Implantable Tibial Nerve Neuromodulator

BlueWind Medical, developer of a miniature wireless neurostimulation platform for the treatment of multiple clinical indications, announced today the ...


Sep 09, 2016, 03:00 ET BlueWind Medical kondigt CE-markering aan voor de implanteerbare draadloze VIVENDI™-miniatuurstimulator van BlueWind ter behandeling van perifere pijn

BlueWind Medical, ontwikkelaar van een miniatuur draadloos neurostimulatieplatform ter behandeling van meerdere klinische aandoeningen, heeft vandaag ...


Sep 07, 2016, 08:50 ET BlueWind Medical gibt die CE-Kennzeichnung für VIVENDI™, den funkgesteuerten implantierten Miniaturstimulator zur Behandlung von peripherer Neuropathie bekannt

BlueWind Medical, Entwickler einer funkgesteuerten Miniaturneurostimulationsplattform zur Behandlung mehrerer Erkrankungen, gab heute bekannt, dass...


Sep 07, 2016, 07:00 ET BlueWind Medical Announces CE-Mark for the BlueWind VIVENDI™ Miniature Implanted Wireless Stimulator to Treat Peripheral Pain

BlueWind Medical, developer of a miniature wireless neurostimulation platform to treat multiple clinical indications, announced today that the...


Sep 07, 2016, 07:00 ET BlueWind Medical annonce l'obtention du marquage CE pour le stimulateur sans fil miniature implanté VIVENDI™ destiné au traitement de la neuropathie périphérique

BlueWind Medical, développeur d'une plate-forme de neurostimulation miniature sans fil pour le traitement de plusieurs indications cliniques, a...


Sep 07, 2016, 07:00 ET BlueWind Medical annuncia l'autorizzazione al marchio CE per VIVENDI™, il suo neurostimolatore wireless miniaturizzato impiantabile destinato al trattamento del dolore neuropatico periferico

BlueWind Medical, azienda sviluppatrice di una piattaforma miniaturizzata di neurostimolazione wireless per il trattamento di molteplici condizioni...


Jun 15, 2016, 07:00 ET BlueWind Medical annuncia l'autorizzazione al marchio CE per il primo in assoluto neurostimolatore wireless miniaturizzato destinato al trattamento della vescica iperattiva

Bluewind Medical, azienda sviluppatrice di una piattaforma miniaturizzata di neurostimolazione wireless per il trattamento di molteplici condizioni...


Jun 15, 2016, 07:00 ET BlueWind Medical gibt CE-Kennzeichnung für den weltweit ersten drahtlosen Miniatur-Neurostimulator zur Behandlung überaktiver Harnblasen bekannt

Bluewind Medical, Entwickler einer drahtlosen Miniatur-Neurostimulationsplattform zur Behandlung von mehreren klinischen Indikationen, gab heute...


Jun 15, 2016, 07:00 ET BlueWind Medical maakt CE-markering bekend voor eerste draadloze miniatuur-neurostimulator ter wereld voor behandeling van een overactieve blaas

Bluewind Medical, ontwikkelaar van een draadloos miniatuur-neurostimulatorplatform voor de behandeling van meerdere klinische indicaties, heeft...


Jun 15, 2016, 07:00 ET BlueWind Medical annonce le marquage CE pour le premier neurostimulateur miniature sans fil au monde à traiter l'hyperactivité vésicale

Bluewind Medical, développeur d'une plateforme de neurostimulation miniature sans fil pour le traitement de plusieurs indications cliniques, a...


Jun 15, 2016, 07:00 ET BlueWind Medical Announces CE-Mark for the First in the World Miniature Wireless Neurostimulator to Treat Overactive Bladder

Bluewind Medical, developer of a miniature wireless neurostimulation platform to treat multiple clinical indications, announced today that the...


Jan 11, 2016, 09:00 ET BlueWind Medical Announces Successful Completion of Patients' Enrolment for Its Overactive Bladder (OAB) Clinical Study Toward a CE Mark

BlueWind Medical, developer of a wireless neuro-stimulation device to treat multiple clinical indications, such as back pain, peripheral neuropathic...


Jan 11, 2016, 04:00 ET BlueWind Medical annonce l'achèvement réussi du recrutement des patients dans le cadre de son étude clinique sur l'hyperactivité vésicale (HAV) en vue d'un marquage CE

L'étude évalue le Bluewind OAB-1000 System, une plateforme de neurostimulation miniature sans fil ni conducteur pour traiter de multiples indications ...


Jan 11, 2016, 04:00 ET BlueWind Medical gibt die erfolgreiche Patientenaufnahme in ihre klinische Studie zur überaktiven Blase bekannt, mit deren Ergebnissen das Unternehmen auf die CE-Kennzeichnung hofft

Die Studie bewertet die Wirkungsweise des Bluewind OAB-1000-Systems, einer drahtlosen Miniatur-Neurostimulationsplattform zur Behandlung vielfältiger ...